网站首页
讨论
商家
资讯
人才
书店
更多
分享
博客
会议
社区
文献
百科
期刊文献
频道首页
/
中外期刊
/
共识指南
/
文献资讯
/
论文基金
首页
>
期刊杂志
>
正文
Is the aberrant expression of p53 by immunocytochemistry a surrogate marker of TP53 mutation and/or deletion in chronic lymphocytic leukemia?
Marinelli M,Raponi S,Del Giudice I,De Propris MS,Nanni M,Intoppa S,Milani ML,Mauro FR,Guarini A,Foà R
阅读:304
American Journal of Clinical Pathology
;
2011 January; 135 (1)
full text
用微信扫描二维码
分享至好友和朋友圈
分享
新浪微博
QQ空间
微信
我要评论
共
0
条评论
本期排行
CD23 expression in follicular ...
Flow cytometry rapidly identif...
A UK NEQAS ISH multicenter rin...
Flow cytometric immunophenotyp...
The clinical pathologist as co...
FLT3 and NPM1 mutations in mye...
Acute myeloid leukemia with ID...
Pure sarcomatoid carcinoma of ...
Pathology consultation on warf...
Utilization management in a la...
共0条评论